Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nichi-Iko Buys Sagent To Strengthen US Biosimilars Presence

Jul 12 2016

• By Mandy Jackson

currency

Related Content

Sagent Turns Generic Injectable Shortages Into Business Opportunity

Jun 23 2014

Nichi-Iko rights offering to support production, biosimilar plans

Nov 29 2013

Aprogen Strikes Third Global Biosimilar Deal With Nichi-Iko

Mar 25 2016

BioNotebook: Two key fires at Retrophin, NewLink; three deals and three financings

Oct 04 2014

Japan's Nichi-Iko prepping for US biosimilar entry

Feb 13 2014

Teva Continues Divestitures To Close Allergan Deal With Sale To Impax

Jun 22 2016

Data Take: Forget Teva and Mylan - Big Pharma Owns Generics

Jun 13 2016

Related Companies

Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Allergan plc

Nichi-Iko Pharmaceutical Co., Ltd.

Additional Topics

Companies Biosimilars Deals BioPharmaceutical

More from Biosimilars

More from Products

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window